AG1 (Athletic Greens): Company Overview, Business Model, and What the Evidence Actually Shows

How AG1 Built a Supplement Empire

AG1 began as Athletic Greens in 2010, founded by Chris Ashenden, a New Zealand entrepreneur who described his goal as creating a single product to replace a shelf of supplements. The company raised over $115 million in venture funding and rebranded to AG1 in 2022. Its go-to-market strategy relies almost entirely on podcast sponsorships and influencer partnerships.

The business model is simple: one SKU, sold by subscription. Customers pay $79 per month for a 30-serving pouch (or $99 for a one-time purchase). AG1 does not sell through Amazon, retail pharmacies, or third-party marketplaces. This direct-to-consumer approach keeps margins high and gives the company full control over pricing, messaging, and customer data.

AG1's marketing positions the product as "foundational nutrition," a category the company essentially invented for branding purposes. The FDA classifies AG1 as a dietary supplement, which means it did not undergo pre-market efficacy review. Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), supplement manufacturers are responsible for ensuring safety, but they are not required to demonstrate clinical efficacy before selling [1]. This regulatory framework is critical context for evaluating any supplement's claims.

The company's influencer strategy deserves scrutiny. AG1 has sponsored hundreds of podcasters, athletes, and social media figures. That does not make the product ineffective. It does mean that most consumer-facing "reviews" carry financial incentives, making independent analysis harder to find.

What Is Actually in the Formula

AG1 contains 75 ingredients grouped into four proprietary blends: a "Raw Superfood Complex," an "Extracts, Herbs & Antioxidants" blend, a "Digestive Enzyme & Mushroom Complex," and a "Dairy-Free Probiotics" blend. The Supplement Facts panel lists exact amounts for 10 vitamins and minerals but uses proprietary blend weights for the remaining 65+ compounds [2].

The vitamin and mineral content is transparent and, in some cases, generous. One serving provides 667 mcg of folate (as methyltetrahydrofolate), 20 mcg of vitamin D3 to 250 mg of vitamin C, and 100 mg of magnesium. Several of these meet or exceed 100% of the Daily Value. Biotin is dosed at 150 mcg, zinc at 12 mg, and selenium at 55 mcg, all within well-established reference ranges from the NIH Office of Dietary Supplements.

The problem lies in the blends. The "Raw Superfood Complex" weighs 7 to 388 mg total and contains spirulina, wheat grass juice powder, inulin, apple powder, and roughly 20 other ingredients. Because FDA labeling rules require blend ingredients to be listed in descending order by weight but do not require individual amounts, there is no way to determine whether spirulina contributes 3 to 000 mg or 300 mg of that total [3]. The same opacity applies to the ashwagandha extract in the adaptogen blend; clinical trials on ashwagandha, such as the Salve (2019) RCT, used 600 mg/day of KSM-66, but the AG1 label does not confirm this dose is present [4].

The 7.2 billion CFU probiotic claim centers on Lactobacillus acidophilus. Probiotic experts, including the International Scientific Association for Probiotics and Prebiotics (ISAPP), emphasize that probiotic benefits are strain-specific and dose-specific [5]. AG1 identifies the species but not the exact strain designation (e.g., L. acidophilus NCFM), making it difficult to match the product to any specific clinical trial.

Does Clinical Evidence Support AG1?

No randomized controlled trial has been published on the AG1 formula. This is the single most important fact in any honest assessment of the product. AG1's website references "nutrient-specific studies," which is a different claim than formula-level evidence. The distinction matters.

Individual ingredients in AG1 do have clinical support. Vitamin D supplementation at 20 mcg/day reduces fracture risk in deficient populations, according to a U.S. Preventive Services Task Force review. The COSMOS trial (N=21,442) found that daily multivitamin use modestly improved episodic memory in adults over 65 after one year (effect size: 0.028 SD per year, P=0.0009) [6]. Magnesium supplementation at doses above 300 mg/day has been associated with improved insulin sensitivity in a meta-analysis of 18 RCTs published in Diabetes Care [7].

These findings apply to the isolated nutrients, not to AG1 as a finished product. Dr. Pieter Cohen, an associate professor at Harvard Medical School and a leading researcher on supplement safety, has stated in published commentary that "the presence of a beneficial ingredient does not mean that a product containing it will deliver the same benefit, particularly when doses are hidden behind proprietary blends" [8]. This principle applies directly to AG1 and every similar greens powder.

One area where AG1 may have indirect support is baseline micronutrient repletion. The CDC's Second Nutrition Report found that approximately 10% of the U.S. population has at least one nutrient deficiency, with vitamin B6, vitamin D, and iron being the most common [9]. A product that supplies 100% or more of the Daily Value for multiple micronutrients could, in theory, help close gaps. But a $6 generic multivitamin does the same thing for the nutrients that are transparently dosed.

AG1 vs. a Standard Multivitamin

The comparison most consumers should make is not AG1 vs. nothing. It is AG1 vs. a USP-verified multivitamin costing $0.10 to $0.30 per day.

A Centrum Silver tablet, for example, provides 25 mcg of vitamin D3 to 150 mcg of folate, 50 mg of calcium, and 11 mg of zinc. It costs roughly $0.15 per day and carries USP Verified Mark certification, meaning an independent lab has confirmed that the tablet contains what it claims and will dissolve properly [10].

AG1 adds botanical extracts, a probiotic blend, and food-derived compounds that a standard multivitamin does not include. Whether those additions justify a 20x price premium depends entirely on whether they are present at clinically meaningful doses. And that is precisely the question the proprietary blend format prevents consumers from answering.

Dr. JoAnn Manson, chief of the Division of Preventive Medicine at Brigham and Women's Hospital and principal investigator of the VITAL trial, has noted: "For most healthy adults eating a reasonably balanced diet, a standard multivitamin is reasonable insurance, but there is limited evidence that more expensive formulations provide additional benefit" [11].

Where AG1 does hold a clear advantage is its NSF Certified for Sport designation. This means the product has been independently tested for over 270 substances banned in competitive athletics, including anabolic agents, stimulants, and diuretics [12]. Athletes subject to anti-doping testing have a legitimate reason to choose NSF-certified products over uncertified alternatives. For a non-athlete consumer, this certification is less relevant.

Cost Analysis and Subscription Economics

AG1's pricing structure merits careful examination. The subscription price of $79 per month ($2.63/day) includes free shipping and a welcome kit. A one-time purchase costs $99 ($3.30/serving). Over 12 months, a subscriber spends $948 on AG1 alone.

For comparison, a year's supply of a USP-verified multivitamin costs roughly $40 to $75. Adding a standalone vitamin D3 supplement (2 to 000 IU/day, $8-12/year), a magnesium glycinate supplement ($15-25/year), and a well-studied probiotic like Culturelle ($180-240/year) brings the annual total to approximately $250 to $350 for individually dosed, evidence-backed products. That is roughly one-third of the AG1 cost, with transparent dosing for every ingredient.

AG1's cancellation process is straightforward (online, no phone call required), and the company offers a 90-day money-back guarantee. The subscription model does create behavioral stickiness. Research on subscription commerce published in the Journal of Marketing Research shows that consumers routinely overestimate how much they will use subscription products and underestimate friction costs of cancellation [13].

Safety Profile and Regulatory Considerations

AG1 has not been associated with serious adverse events in FDA's CAERS (Center for Food Safety and Applied Nutrition Adverse Event Reporting System) database to date. The NSF Certified for Sport program adds a meaningful layer of safety verification that many competitors lack.

Potential concerns exist for specific populations. AG1 provides 667 mcg DFE of folate per serving. Combined with folate from fortified foods, total intake could approach the NIH's tolerable upper intake level of 1 to 000 mcg/day for synthetic folic acid equivalents [14]. For individuals without MTHFR variants or pregnancy-related needs, this level is likely unnecessary.

The product contains wheat grass and barley grass, which are gluten-containing grains. AG1 states these are harvested before the seed forms, when gluten content is minimal, and the product is tested to contain fewer than 20 ppm of gluten (the FDA threshold for "gluten-free" labeling). Individuals with celiac disease should discuss this with their gastroenterologist before using the product [15].

Ashwagandha, present in the adaptogen blend, has been linked to rare cases of liver injury in post-marketing surveillance. An NIH LiverTox review documents at least 20 published case reports of ashwagandha-associated hepatotoxicity, most resolving after discontinuation [16]. The clinical significance depends on dose, which AG1 does not disclose.

Who Might Reasonably Consider AG1

Three groups may find AG1 offers practical value. Tested athletes who need NSF Certified for Sport assurance have a short list of certified options, and AG1 is one of them. Frequent travelers or people with genuinely poor dietary patterns who want a single-product solution might prefer the convenience, though they should not assume it replaces whole foods.

People who dislike swallowing pills represent a real (and underappreciated) adherence barrier in supplement use. A 2021 survey published in Patient Preference and Adherence found that 40% of American adults report difficulty swallowing tablets, with 14% delaying or skipping doses as a result [17]. A powder mixed into water sidesteps this issue entirely.

For everyone else, the evidence-based recommendation is straightforward. A USP-verified multivitamin covers the micronutrients with known benefit. If specific deficiencies are identified through bloodwork, targeted supplementation at validated doses is more precise and dramatically cheaper than a broad-spectrum blend with hidden dosing.

How AG1 Compares to Other Greens Powders

The greens-powder market has expanded significantly since AG1's launch. Competitors include Bloom Greens, Seed DS-01 (a synbiotic, not a greens powder, but frequently compared), and Transparent Labs Prebiotic Greens.

AG1's competitive advantages are its NSF Certified for Sport status (Bloom and most competitors lack this), its single-product simplicity, and its long track record (15+ years on market). Its disadvantages are price (Bloom costs roughly $1.07/day; Transparent Labs, $1.33/day), proprietary blend opacity (Transparent Labs discloses individual ingredient doses), and the absence of published clinical trials on its formula.

A 2022 analytical study published in the Journal of Dietary Supplements tested 12 commercial greens powders and found that actual polyphenol content varied from 24% to 157% of label claims [18]. This variability underscores why third-party certification matters, but it also highlights that label claims across the entire category should be treated with skepticism until independently verified.

Seed DS-01, while not a direct competitor, represents a different philosophy: two clinically studied probiotic strains at published doses, with no proprietary blends. The tradeoff is that DS-01 provides no vitamins or minerals. Consumers comparing the two are really choosing between a kitchen-sink approach (AG1) and a targeted, strain-specific approach (Seed).

The Bottom Line for Clinicians and Patients

AG1 is a legal, NSF-certified, well-manufactured product that provides a meaningful dose of several essential vitamins and minerals in a convenient powder format. It is not evidence-based in the way that term is used in clinical medicine, because no RCT has tested its specific formula against placebo for any health outcome.

The American Academy of Family Physicians does not recommend routine multivitamin supplementation for well-nourished adults, noting that evidence of benefit is limited for most healthy populations [19]. The USPSTF assigned a grade of "I" (insufficient evidence) to multivitamin supplementation for cardiovascular disease and cancer prevention in 2022, while noting that individual nutrients like folic acid have clear benefit in specific contexts (pregnancy) [20].

Patients asking about AG1 should receive a direct answer. The vitamins and minerals in it are fine. The proprietary blends are unverifiable. The price is high relative to alternatives. And no amount of podcast sponsorship changes the fact that clinical evidence requires a published trial, which AG1 has not produced after 15 years on the market. Clinicians should recommend baseline bloodwork (CBC, CMP, 25-OH vitamin D, B12, ferritin, magnesium) before any supplementation, targeted repletion of confirmed deficiencies, and a USP-verified multivitamin if broad coverage is desired at 5% of the cost.